Showing results (1151-1160 of 5,269) with videos related to

Sort By:
Pageof 527
European Journal of Haematology|March 23, 2023
Clinical outcomes of patients referred for asymptomatic neutropenia: A focus on racial disparities in hematologyEmmanuella Oyogoa, Rick Mathews, Sven Olson, et al.
European Journal of Haematology|March 23, 2023
Safety, feasibility, and neuromuscular activity of acute low-load resistance exercise with or without blood flow restriction in patients with severe hemophiliaJoaquín Calatayud, Daniel C Ogrezeanu, Juan J Carrasco, et al.
European Journal of Haematology|March 22, 2023
Incidence, prognostic factors, and survival outcomes in patients with blastic plasmacytoid dendritic cell neoplasm: A retrospective study in the Surveillance, Epidemiology, and End Results databaseXiaojing Lin, Li Wang, Qian Hu, et al.
European Journal of Haematology|March 25, 2023
Trajectories of the SARS-CoV-2 RNA load in patients with hematological malignancySatoshi Mitsuyuki, Masashi Nishikubo, Yoshimitsu Shimomura, et al.
European Journal of Haematology|October 1, 1987
Cytogenetic and immunologic characterization of mitotic cells in chronic lymphocytic leukaemiaK Autio, E Elonen, L Teerenhovi, et al.
European Journal of Haematology|November 1, 1987
Single-dose pharmacokinetics of factor IX evaluated by model-independent methodsG Longo, S Cinotti, E Filimberti, et al.
European Journal of Haematology|November 1, 1987
Hb Linköping (beta 36 Pro----Thr): a new high oxygen affinity hemoglobin variant found in two families of Finnish originG Berlin, B Wranne, J O Jeppsson
European Journal of Haematology|November 1, 1987
A benign course of multicentric Castleman's disease with involvement of the spleen and bone marrowY Levo, A J Behar, I Blum, et al.
European Journal of Haematology|March 20, 2023
Venous thromboembolism in metastatic pancreatic cancerLauren Laderman, Krishnalatha Sreekrishnanilayam, Ramesh K Pandey, et al.
European Journal of Haematology|March 21, 2023
Dose-adjusted EPOCH and rituximab (DA-EPOCH-R) in older patients with high-risk aggressive diffuse large B-cell lymphoma: A real-life multicenter study by the Croatian Cooperative Group for Hematologic diseases (KroHem)Zdravko Mitrovic, Dino Dujmovic, Ozren Jaksic, et al.
Pageof 527